Skip Nav Destination
Improving evidence on anticoagulant therapies for venous thromboembolism in children: key challenges and opportunities
Treatment and survival among 1594 patients with ATL
Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment
Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations
Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions
Issue Archive
December 10 2015
In this Issue
Table of Contents
EDITORIAL
BLOOD FLASHBACK
INSIDE BLOOD COMMENTARIES
PERSPECTIVES
Improving evidence on anticoagulant therapies for venous thromboembolism in children: key challenges and opportunities
Clinical Trials & Observations
BLOOD FORUM
REVIEW ARTICLE
CLINICAL TRIALS AND OBSERVATIONS
Treatment and survival among 1594 patients with ATL
Clinical Trials & Observations
Hiroo Katsuya,on behalf of the ATL–Prognostic Index Project,Kenji Ishitsuka,on behalf of the ATL–Prognostic Index Project,Atae Utsunomiya,on behalf of the ATL–Prognostic Index Project,Shuichi Hanada,on behalf of the ATL–Prognostic Index Project,Tetsuya Eto,on behalf of the ATL–Prognostic Index Project,Yukiyoshi Moriuchi,on behalf of the ATL–Prognostic Index Project,Yoshio Saburi,on behalf of the ATL–Prognostic Index Project,Masaharu Miyahara,on behalf of the ATL–Prognostic Index Project,Eisaburo Sueoka,on behalf of the ATL–Prognostic Index Project,Naokuni Uike,on behalf of the ATL–Prognostic Index Project,Shinichiro Yoshida,on behalf of the ATL–Prognostic Index Project,Kiyoshi Yamashita,on behalf of the ATL–Prognostic Index Project,Kunihiro Tsukasaki,on behalf of the ATL–Prognostic Index Project,Hitoshi Suzushima,on behalf of the ATL–Prognostic Index Project,Yuju Ohno,on behalf of the ATL–Prognostic Index Project,Hitoshi Matsuoka,on behalf of the ATL–Prognostic Index Project,Tatsuro Jo,on behalf of the ATL–Prognostic Index Project,Masahiro Amano,on behalf of the ATL–Prognostic Index Project,Ryosuke Hino,on behalf of the ATL–Prognostic Index Project,Mototsugu Shimokawa,on behalf of the ATL–Prognostic Index Project,Kazuhiro Kawai,on behalf of the ATL–Prognostic Index Project,Junji Suzumiya,on behalf of the ATL–Prognostic Index Project,Kazuo Tamura,on behalf of the ATL–Prognostic Index Project
LYMPHOID NEOPLASIA
Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment
Clinical Trials & Observations
Gerhard Zugmaier,Nicola Gökbuget,Matthias Klinger,Andreas Viardot,Matthias Stelljes,Svenja Neumann,Heinz-A. Horst,Reinhard Marks,Christoph Faul,Helmut Diedrich,Albrecht Reichle,Monika Brüggemann,Chris Holland,Margit Schmidt,Hermann Einsele,Ralf C. Bargou,Max S. Topp
MYELOID NEOPLASIA
Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations
Clinical Trials & Observations
Emmanuelle Verger,Bruno Cassinat,Aurélie Chauveau,Christine Dosquet,Stephane Giraudier,Marie-Hélène Schlageter,Jean-Christophe Ianotto,Mohammed A. Yassin,Nader Al-Dewik,Serge Carillo,Eric Legouffe,Valerie Ugo,Christine Chomienne,Jean-Jacques Kiladjian
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
slan-defined subsets of CD16-positive monocytes: impact of granulomatous inflammation and M-CSF receptor mutation
Thomas P. Hofer,Adam M. Zawada,Marion Frankenberger,Kerstin Skokann,Anna A. Satzl,Wolfgang Gesierich,Madeleine Schuberth,Johannes Levin,Adrian Danek,Björn Rotter,Gunnar H. Heine,Loems Ziegler-Heitbrock
PLATELETS AND THROMBOPOIESIS
RED CELLS, IRON, AND ERYTHROPOIESIS
TRANSPLANTATION
Discordance in lymphoid tissue recovery following stem cell transplantation in rhesus macaques: an in vivo imaging study
Robert E. Donahue,Sharat Srinivasula,Naoya Uchida,Insook Kim,Alexis St. Claire,Gorka Duralde,Paula DeGrange,Marisa St. Claire,Richard C. Reba,Aylin C. Bonifacino,Allen E. Krouse,Mark E. Metzger,Chang H. Paik,H. Clifford Lane,John F. Tisdale,Michele Di Mascio
BLOOD WORK
CORRESPONDENCE
Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions
Clinical Trials & Observations
Ciara L. Freeman,Franck Morschhauser,Laurie Sehn,Mark Dixon,Richard Houghton,Thierry Lamy,Günter Fingerle-Rowson,Elisabeth Wassner-Fritsch,John G. Gribben,Michael Hallek,Gilles Salles,Guillaume Cartron
Dramatic transient improvement of metastatic BRAFV600E-mutated Langerhans cell sarcoma under treatment with dabrafenib
Samia Mourah,Gwenaël Lorillon,Véronique Meignin,Laetitia Vercellino,Constance de Margerie-Mellon,Cécile Pages,Lauriane Goldwirt,Alexandre How-Kit,Jorg Tost,Céleste Lebbe,Abdellatif Tazi
-
Cover Image
Cover Image
![issue cover]()
In honor of the 70th anniversary of Blood in 2016, this issue is being published in conjunction with the 2015 Annual Meeting of the American Society of Hematology. The special features of the anniversary issue include an editorial by Blood's Editor-in-Chief, Dr Bob Löwenberg; a Blood Forum by Dr Barry Coller about the history of hematology and Blood; and the first in a series of Blood Flashback pieces highlighting articles from the first 4 decades of the journal that had powerful impacts on hematology. In addition to Blood Flashbacks, in 2016 the journal will feature a series of editorials written by past Blood Editors-in-Chief. Each of these special 70th-anniversary editorials will discuss one or more important articles that were published in Blood during their tenure as Editor-in-Chief. The cover design for the anniversary issue is by Brian Cannon of the Blood editorial staff.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
